Asia Pacific Pre-filled syringes Market Outlook

asia pacific pre-filled syringes markets are poised for exponential growth in the next decade as the number of drug treatments requiring injections continues to increase, with growing demand in both developed and developing countries. the growing prevalence of chronic conditions such as diabetes, cardiovascular disease, and cancer is spurring growth in the pre-filled syringes market in the asia pacific region. according to centers for disease control and prevention (cdc), more than a third of adults in india in 2018 were living with a chronic illness, compared to only 20% in 2005. this long-term health condition means that a steady and uninterrupted supply of medication is needed for sufferers to manage their conditions. the increasing prevalence of cancer cases is also driving up demand for pre-filled syringes. asia pacific is the epicenter for cancer disease, accounting for about 60% of the new cases and 70% of the cancer related deaths in 2018. with 2016 data showing that cancer patients in china have the highest hospitalization frequency, the demand for pre-filled syringes is only set to increase. the high cost of developing new drugs and the growing price pressures on existing medications has also pushed pharmaceutical companies to invest in technologies that can reduce errors and issues related to drug delivery. pre-filled syringes are seen as one of the best options for this due to the convenience, accuracy and safety they provide over traditional syringes. the growth of the asia pacific pre-filled syringes market will also be bolstered by the growing number of clinical studies involving biologics. this is because biologics require specialized and expensive injection devices for delivery, making pre-filled syringes the primary option for distribution. the increasing use of vaccines and growing digital health markets in the asia pacific region are both expected to provide additional growth for pre-filled syringes markets in the near future. developing countries such india and china are expected to be major drivers of growth due to their strong base of anti-infective vaccines and rising demand for convenience in the healthcare sector. enhanced safety features, improved disposability and the development of new needleless injection systems are some of the major factors that will drive long-term growth in pre-filled syringes markets in the asia pacific region.